CLINICAL_TRIALS
trial_result
· 2015-01-07
Clinical Trial Update: IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen [Phase 2]
Summary
A Phase 2 trial evaluating abiraterone acetate's effect on PSA in men with prostate cancer completed and results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Biotech, Inc. | Conditions: Prostate Cancer, Prostatic Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2015-01-07